ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1000

Obesity and Foot Problems in the Framingham Foot Study:  Does Foot Structure or Foot Function Protect Against Hallux Valgus?

Alyssa B. Dufour1, Elena Losina2, Michael P. Lavalley3, David Gagnon4,5, Hylton B. Menz6 and Marian T. Hannan7, 1Institute for Aging Research, Hebrew SeniorLife, Harvard Medical School & Beth Israel Deaconess Medical Center, Boston, MA, 2Orthopaedic and Arthritis Center for Outcomes Research, Department of Orthopaedic Surgery, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, 3Biostatistics, Boston University, Boston, MA, 4Biostatistics Department, Boston University School of Public Health, Boston, MA, 5MAVERIC, VA Boston Health Care, Boston, MA, 6Musculoskeletal Research Centre, La Trobe University, Bundoora, VIC, Australia, 7Institute for Aging Research, Hebrew SeniorLife, Dept. of Medicine Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: foot, foot disorders, obesity and population studies

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 8, 2015

Title: ARHP I: Exemplary Abstracts

Session Type: ARHP Concurrent Abstract Session

Session Time: 2:30PM-4:00PM

Background/Purpose: Obesity and foot problems are common in older adults and associated with many negative health outcomes. There is limited evidence examining the relation between foot problems and obesity from a population perspective. Previous studies have found higher BMI to be linked with reduced odds of hallux valgus, a common foot disorder, but no study has determined the reason for this unexpected relation. The purpose of this study was to describe the associations between obesity categories, with foot pain and foot disorders (hallux valgus, claw, hammer, overlapping toes), and to determine if these associations differ by foot structure or by foot function in a community-based, cross-sectional study of older men and women.

Methods: We included 2445 participants (contributing 4888 feet) from the Framingham Foot Study between 2002 and 2008. A podiatric-trained examiner performed a validated examination of participantsÕ feet to determine the presence of foot disorders on each foot by comparing the foot to a laminated depiction of the disorder. Foot pain was defined by the question ÒOn most days, do you have pain, aching or stiffness in either foot?Ó Body mass index (BMI, kg/m2) was determined at the time of the foot exam and categorized as normal (<25, referent), overweight (25-30), moderately obese (30-35) and severely obese (35+). Foot structure (cavus, planus) and foot function (pronated, supinated) were defined using the Tekscan Matscan pressure system as the modified arch index and the center of pressure excursion index, respectively. We used sex-specific logistic regression, adjusting for within person correlation, to examine the relation between foot pain and each foot disorder with obesity categories, adjusting for age and further stratified by foot structure and foot function categories in a foot-specific analysis.

Results: Average age was 68 (SD 11) years, 56% were female, BMI was 28 (SD 5) kg/m2. 18% of feet had pain, 25% hallux valgus, 2% claw toes, 18% hammer toes, 7% overlapping toes. Severely obese men were more likely to have foot pain (OR=2.4; 95% CI: 1.4-4.3) and claw toes (OR=3.4; 95% CI: 1.1-10.7) compared to normal weight men. In women, there was an increased odds of foot pain with all categories of obesity (Table). Severely obese women were 40% less likely to have hallux valgus (OR=0.61; 95% CI: 0.4-0.9) compared to normal weight women. We saw the same effect in men although it did not reach statistical significance. Patterns of association were the same stratified by foot structure or function in men or in women.

Conclusion: Women are more prone to foot pain and obese women, even more so. Reducing weight may reduce pain and potentially reduce foot problems. Foot structure and foot function do not change the associations between foot problems and obesity. Further studies are needed to determine the mechanism behind these associations and the role of longitudinal trajectories of BMI on foot problems.

Table. Per-foot analysis of the association between obesity categories (referent group BMI < 25 kg/m2) and foot pain and foot disorders, adjusting for age.

Obesity category

Men

2150 feet; 1076 people

Women

2738 feet; 1369 people

N 

OR(95% CI)

N 

OR(95% CI)

Foot pain

Normal (referent)

50/300

1.0

140/569

1.0

Overweight

116/300

1.06 (0.67,1.67)

192/567

1.49 (1.09,2.03)**

Moderately obese

82/300

1.17 (0.71,1.91)

139/567

2.01 (1.43,2.81)**

Severely obese

52/300

2.44 (1.38,4.33)**

96/567

3.21 (2.15,4.79)*

Hallux valgus

Normal (referent)

71/323

1.0

350/919

1.0

Overweight

150/323

1.01 (0.68,1.50)

338/919

0.97 (0.76,1.24)

Moderately obese

81/323

0.84 (0.54,1.31)

168/919

0.81 (0.61,1.09)

Severely obese

21/323

0.61 (0.31,1.18)

63/919

0.61 (0.40,0.93)*

Claw toes

Normal (referent)

8/44

1.0

25/65

1.0

Overweight

16/44

1.23 (0.46,3.27)

24/65

1.05 (0.49,2.24)

Moderately obese

13/44

1.89 (0.65,5.49)

11/65

0.97 (0.38,2.45)

Severely obese

7/44

3.37 (1.06,10.66)*

5/65

1.14 (0.33,3.91)

Hammer toes

Normal (referent)

79/369

1.0

198/501

1.0

Overweight

146/369

0.93 (0.64,1.35)

158/501

0.78 (0.58,1.05)

Moderately obese

103/369

1.11 (0.74,1.66)

97/501

0.94 (0.66,1.33)

Severely obese

41/369

1.37 (0.79,2.37)

48/501

1.13 (0.72,1.76)

Overlapping toes

Normal (referent)

28/112

1.0

82/212

1.0

Overweight

44/112

0.86 (0.47,1.57)

74/212

0.97 (0.65,1.44)

Moderately obese

30/112

1.03 (0.53,1.99)

43/212

1.15 (0.70,1.88)

Severely obese

10/112

1.06 (0.43,2.62)

13/212

0.87 (0.40,1.88)

* p<0.05; ** p<0.01;

 N = number in the BMI group with the foot problem divided by the number with the foot problem


Disclosure: A. B. Dufour, None; E. Losina, None; M. P. Lavalley, None; D. Gagnon, None; H. B. Menz, None; M. T. Hannan, None.

To cite this abstract in AMA style:

Dufour AB, Losina E, Lavalley MP, Gagnon D, Menz HB, Hannan MT. Obesity and Foot Problems in the Framingham Foot Study:  Does Foot Structure or Foot Function Protect Against Hallux Valgus? [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/obesity-and-foot-problems-in-the-framingham-foot-study-does-foot-structure-or-foot-function-protect-against-hallux-valgus/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/obesity-and-foot-problems-in-the-framingham-foot-study-does-foot-structure-or-foot-function-protect-against-hallux-valgus/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology